Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Expert Opinion on Therapeutic Patents
|
July 24, 2012
5HT(6) receptor antagonists: a patent update. Part 1. Sulfonyl derivatives
Alexandre V Ivachtchenko, Yan A Ivanenkov
Pharmaceutical Patent Analyst
|
December 21, 2013
Small-molecule arginase inhibitors
Yan A Ivanenkov, Nina V Chufarova
Molecular Pharmaceutics
|
February 18, 2016
AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer's Disease
Alexandre V Ivachtchenko, Yan Lavrovsky, Yan A Ivanenkov
Journal of Medicinal Chemistry
|
June 13, 2019
Are We Opening the Door to a New Era of Medicinal Chemistry or Being Collapsed to a Chemical Singularity?
Yan A Ivanenkov, Bogdan A Zagribelnyy, Vladimir A Aladinskiy
Expert Opinion on Therapeutic Patents
|
September 11, 2012
5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds
Alexandre V Ivachtchenko, Yan A Ivanenkov, Andrey V Skorenko
Journal of Chemical Information and Modeling
|
February 6, 2023
SiteRadar: Utilizing Graph Machine Learning for Precise Mapping of Protein-Ligand-Binding Sites
Sergei A Evteev, Alexey V Ereshchenko, Yan A Ivanenkov
Expert Opinion on Therapeutic Patents
|
August 19, 2010
5-hydroxytryptamine subtype 6 receptor modulators: a patent survey
Alexandre V Ivachtchenko, Yan A Ivanenkov, Sergey E Tkachenko
Drug Discovery Today
|
June 13, 2009
Computational mapping tools for drug discovery
Yan A Ivanenkov, Nikolay P Savchuk, Sean Ekins, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
September 28, 2007
Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective
Konstantin V Balakin, Yan A Ivanenkov, Alex S Kiselyov, et al.
Current Alzheimer Research
|
November 11, 2016
AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models
Alexandre V Ivachtchenko, Yan A Ivanenkov, Mark S Veselov, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Expert Opinion on Therapeutic Patents
|
July 24, 2012
5HT(6) receptor antagonists: a patent update. Part 1. Sulfonyl derivatives
Alexandre V Ivachtchenko, Yan A Ivanenkov
Pharmaceutical Patent Analyst
|
December 21, 2013
Small-molecule arginase inhibitors
Yan A Ivanenkov, Nina V Chufarova
Molecular Pharmaceutics
|
February 18, 2016
AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer's Disease
Alexandre V Ivachtchenko, Yan Lavrovsky, Yan A Ivanenkov
Journal of Medicinal Chemistry
|
June 13, 2019
Are We Opening the Door to a New Era of Medicinal Chemistry or Being Collapsed to a Chemical Singularity?
Yan A Ivanenkov, Bogdan A Zagribelnyy, Vladimir A Aladinskiy
Expert Opinion on Therapeutic Patents
|
September 11, 2012
5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds
Alexandre V Ivachtchenko, Yan A Ivanenkov, Andrey V Skorenko
Journal of Chemical Information and Modeling
|
February 6, 2023
SiteRadar: Utilizing Graph Machine Learning for Precise Mapping of Protein-Ligand-Binding Sites
Sergei A Evteev, Alexey V Ereshchenko, Yan A Ivanenkov
Expert Opinion on Therapeutic Patents
|
August 19, 2010
5-hydroxytryptamine subtype 6 receptor modulators: a patent survey
Alexandre V Ivachtchenko, Yan A Ivanenkov, Sergey E Tkachenko
Drug Discovery Today
|
June 13, 2009
Computational mapping tools for drug discovery
Yan A Ivanenkov, Nikolay P Savchuk, Sean Ekins, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
September 28, 2007
Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective
Konstantin V Balakin, Yan A Ivanenkov, Alex S Kiselyov, et al.
Current Alzheimer Research
|
November 11, 2016
AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models
Alexandre V Ivachtchenko, Yan A Ivanenkov, Mark S Veselov, et al.
Page
of 8